These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16163421

  • 1. [Prevention of community-acquired pneumonia in adults].
    Barros M M, Cartagena S C, Bavestrello F L.
    Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
    [Abstract] [Full Text] [Related]

  • 2. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS.
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C, EVAN Study Group.
    Clin Infect Dis; 2006 Oct 01; 43(7):860-8. PubMed ID: 16941367
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW, Vaccine Safety Datalink.
    N Engl J Med; 2003 May 01; 348(18):1747-55. PubMed ID: 12724480
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
    Ludwig E, Mészner Z, Hungarian Society of Infectious Disease and Clinical Microbiology, Vaccinology Section.
    Orv Hetil; 2014 Dec 14; 155(50):1996-2004. PubMed ID: 25481502
    [Abstract] [Full Text] [Related]

  • 6. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
    Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA.
    Vaccine; 2007 Jun 06; 25(23):4631-40. PubMed ID: 17478015
    [Abstract] [Full Text] [Related]

  • 7. [Pneumococcal vaccination in adults].
    Jonkers RE, Boersma WG.
    Ned Tijdschr Geneeskd; 2003 Mar 08; 147(10):437-41. PubMed ID: 12666513
    [Abstract] [Full Text] [Related]

  • 8. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
    Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM, Gruber WC, Tansey S, McDonough A, Thoma B, Patterson S, van Alphen AJ, Bonten MJ.
    Neth J Med; 2008 Oct 08; 66(9):378-83. PubMed ID: 18990781
    [Abstract] [Full Text] [Related]

  • 9. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I, Lindley IR, Gao Z, McIntyre P, Macintyre CR.
    Vaccine; 2008 Oct 16; 26(44):5633-40. PubMed ID: 18706955
    [Abstract] [Full Text] [Related]

  • 10. Pneumonia in older persons.
    Loeb M.
    Clin Infect Dis; 2003 Nov 15; 37(10):1335-9. PubMed ID: 14583867
    [Abstract] [Full Text] [Related]

  • 11. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
    Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR.
    Clin Infect Dis; 2010 Jul 01; 51(1):15-22. PubMed ID: 20504233
    [Abstract] [Full Text] [Related]

  • 12. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, Ochoa-Gondar O, de Diego C, Valdivieso A, Hospital I, Gomez-Bertomeu F, Raga X.
    Vaccine; 2009 Mar 04; 27(10):1504-10. PubMed ID: 19171174
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.
    Pediatrics; 2009 Jun 04; 123(6):e1103-10. PubMed ID: 19482744
    [Abstract] [Full Text] [Related]

  • 14. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
    Valencia Ortega ME, González Lahoz JM.
    An Med Interna; 1998 Aug 04; 15(8):439-42. PubMed ID: 9780428
    [Abstract] [Full Text] [Related]

  • 15. Vaccines for persons at high risk, 2007.
    Zimmerman RK, Middleton DB.
    J Fam Pract; 2007 Feb 04; 56(2 Suppl Vaccines):S38-46, C4-5. PubMed ID: 17270109
    [Abstract] [Full Text] [Related]

  • 16. Lower respiratory tract infections: prevention using vaccines.
    Whitney CG, Harper SA.
    Infect Dis Clin North Am; 2004 Dec 04; 18(4):899-917. PubMed ID: 15555831
    [Abstract] [Full Text] [Related]

  • 17. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS.
    Semin Respir Infect; 1993 Dec 04; 8(4):285-93. PubMed ID: 7938925
    [Abstract] [Full Text] [Related]

  • 18. [23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010].
    Ripoll M E, Valenzuela B MT, Vergara F R, Abarca V K, Muñoz M A, Jiménez de la Jara J, Pinto C ME, Luchsinger F V.
    Rev Chilena Infectol; 2010 Apr 04; 27(2):133-7. PubMed ID: 20556313
    [Abstract] [Full Text] [Related]

  • 19. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.
    Clin Ther; 2008 Feb 04; 30(2):341-57. PubMed ID: 18343273
    [Abstract] [Full Text] [Related]

  • 20. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb 04; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.